Participants
non-alcoholic fatty liver
BLIND, NON-ALCOHOLIC FATTY LIVER
This study used a pretest–posttest experimental design. The sample size was estimated as 14 in each group by using the G* power software V 3.1.9.2 based on a previous study which compared the efficacy of aerobic training and resistance training on liver enzyme levels in patients with non-alcoholic fatty liver using the variable ALT, effect size 0.98, an alpha level of 0.05 and power (1- beta) of 0.8Consolidated standards of reporting trials (CONSORT) flowchart showing the number of participants assessed for eligibility, randomized and analyzed during the study.The outcome assessor was also blind to the randomization/allocation of participants. The first group, the aerobic group, was designated the "experimental group (EG)," whereas the second group was named the "control group (CG)." Before inclusion into the study, the risk and benefits of the study were discussed with every participant and written informed consent was taken from them. The study was presented to the institutional review board of Aligarh Muslim University, Aligarh, India, which approved it (ID: DN 4900/FSS on 1/9/2021). The study complied with “The Code of Ethics of the World Medical Association (Declaration of Helsinki)”. All methods were performed in accordance with the relevant guidelines and regulations. The study has been registered retrospectively in the protocol registration and results system (clinicaltrials.gov, ID: NCT05704608 on 30/01/2023).